Breaking: FDA calls for removal Of dangerous Opioid painkiller from the market
The FDA, U.S. Food & Drug Association, has requested that Endo Pharmaceuticals remove their reformulated Opana ER (oxymorphone hydrochloride) opioid pain medication from the market. This is the first time the FDA has ever asked for the removal of a previously approved medication. RELATED ARTICLES: Unless You’d Consider Heroin, Don’t Take This Prescription Drug Opioid Abuse Plummets in States with Legal Marijuana The FDA found that the risks of Opana ER currently outweigh the benefits because it is an easily abused drug. FDA Commissioner Scott Gottlieb, M.D. states: “We are facing an opioid epidemic – a public health crisis,...
Read More






